HomeCLVLF • OTCMKTS
add
Clinuvel Pharmaceuticals Limited
Previous close
$6.90
Year range
$6.90 - $11.55
Market cap
574.20M AUD
Avg Volume
32.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 27.69M | 13.12% |
Operating expense | 7.71M | 3.95% |
Net income | 12.35M | 28.53% |
Net profit margin | 44.60 | 13.63% |
Earnings per share | — | — |
EBITDA | 17.42M | 16.59% |
Effective tax rate | 31.15% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 183.87M | 17.25% |
Total assets | 231.12M | 19.31% |
Total liabilities | 28.11M | -3.34% |
Total equity | 203.01M | — |
Shares outstanding | 50.08M | — |
Price to book | 1.70 | — |
Return on assets | 18.75% | — |
Return on capital | 21.26% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 12.35M | 28.53% |
Cash from operations | 5.34M | -32.82% |
Cash from investing | -6.51M | -36.15% |
Cash from financing | -468.66K | -896.51% |
Net change in cash | -1.81M | -150.38% |
Free cash flow | 10.42M | -6.76% |
About
Founded
1987
Website
Employees
16
